Neuron- specific enolase level in patients with metabolic syndrome and its value forecasting acute stroke

Oral B. Ospanov, Kadisha Ospanova, Irina Kadyrova

2018

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.21767/amj.2018.3353
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

BackgroundPatients with metabolic syndrome are at a greater risk of experiencing a cerebrovascular event.Several studies show that patients with metabolic syndrome have asymptomatic ischemic brain injury.In this case, there is a need for rapid determination of asymptomatic brain lesions and prediction of acute stroke. AimsThe aim of the study was to determine the neuron-specific enolase (NSE) serum level in patients with metabolic syndrome and the value of this level for forecasting acute stroke. MethodsThe study used the following information to determine metabolic syndrome: waist circumference, total cholesterol, triglycerides, high-density lipoprotein cholesterol, blood pressure, and blood glucose.Doppler sonography mapping of the brachiocephalic trunk was held to determine the percentage of the carotid artery stenosis.To determine asymptomatic ischemic brain injury, the NSE serum marker was measured.Statistical processing of the measurements was performed using the H test and the Mann-Whitney test.The possible link between MS and NSE were determined by logistic regression analysis.Mathematical modeling was performed using logistic regression. ResultsThere are statistically significant differences in NSE concentrations in groups with metabolic syndrome and ischemic stroke patients.This assertion is confirmed by logistic regression analysis, which revealed the existence of a relationship between metabolic syndrome and increased concentration of NSE. ConclusionPatients with metabolic syndrome have an increased concentration of NSE.This indicates the presence of asymptomatic ischemic neuronal damage.A prognostic model for determining the probability that patients with metabolic syndrome will have an acute stroke was developed.